^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ralimetinib (LY 2228820)

    i
    Other names: LSN-2322600, LY-2228820, LY 2228820, LY2228820
    Associations
    News
    Trials
    Company:
    Eli Lilly
    Drug class:
    MAPK inhibitor, p38 inhibitor
    Related drugs:
    Associations
    News
    Trials